The Weinstock Laboratory uses a range of approaches at the intersection of genetics, DNA repair, and mouse modeling to address the ontogeny, pathogenesis, and therapeutic targeting of lymphoid neoplasms.

Our goal is to identify new prognostic markers and therapeutic targets, and translate them into better outcomes for people with lymphoma and leukemia.

We developed the Public Repository of Xenografts to establish and share human cancer xenografts with academic and industrial partners around the world. We also lead a center for T-cell lymphoma research with close collaborators across the U.S.

Click on this link for Dr. Weinstock's overview of updates in genomics and classifications in T-cell and B-cell lymphomas: